REG - Avacta Group PLC - Director/PDMR Shareholdings and TVR
02/09/2024 16:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240902:nRSB5844Ca&default-theme=true
RNS Number : 5844C Avacta Group PLC 02 September 2024
2 September 2024
Avacta Group plc
("Avacta", the "Group" or the "Company")
Director/PDMR Shareholdings
and
Total Voting Rights
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative,
targeted oncology drugs and powerful diagnostics, announces that a total of
3,600,000 options over ordinary shares of 10p each ("Ordinary Shares") were
granted to Christina Coughlin, MD, PhD, Chief Executive Officer (the
"Options") on 30 August 2024.
The Options were granted under the Company's Long Term Incentive Plan, Avacta
Group plc Executive Share Option Scheme and are time-based, vesting in three
equal tranches over three years to 1 May 2027. The exercise price of the
Options is 72p, being the closing mid-market share price of the Company's
ordinary shares on the 29 August 2024.
Also on 30 August 2024, Tony Gardiner, CFO, exercised 500,000 options and sold
the resulting ordinary shares of 10p each at an average price of 71.07 pence
per share. The exercise price of the options was 10p per ordinary share.
Tony Gardiner continues to retain 2,328,324 options over Ordinary Shares.
As previously announced Tony Gardiner stepped down from the Board on 26 June
2024 but will be remaining as CFO until 31(st) October 2024 whilst the search
for a new permanent CFO is undertaken.
Following the allotment of the 500,000 ordinary shares issued as a result of
the exercise of options by Tony Gardiner, the Company's enlarged issued share
capital is 362,159,730 ordinary shares of 10p each. This figure may be used by
shareholders in the Company as the denominator for the calculations by which
they will determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under the
Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
-Ends-
For further information from Avacta Group plc, please contact:
Avacta Group plc Tel: +44 (0) 1904 21 7070
Christina Coughlin, CEO www.avacta.com (http://www.avacta.com/)
Michael Vinegrad, Group Communications Director
Peel Hunt (Nomad and Broker) www.peelhunt.com (http://www.peelhunt.com/)
James Steel / Chris Golden / Patrick Birkholm
ICR Consilium
Mary-Jane Elliott / Jessica Hodgson / Sukaina Virji avacta@consilium-comms.com (mailto:avacta@consilium-comms.com)
About Avacta Group plc - www.avacta.com (https://avacta.com/)
Avacta Group is a UK-based life sciences company focused on improving
healthcare outcomes through targeted cancer treatments and diagnostics.
Avacta Therapeutics: a clinical stage oncology biotech division harnessing
proprietary therapeutic platforms to develop novel, highly targeted cancer
drugs.
Avacta Diagnostics focuses on supporting healthcare professionals and
broadening access to diagnostics.
Avacta has two proprietary platforms, pre|CISION™ and Affimer(®).
The pre|CISION™ platform is a highly specific substrate for fibroblast
activation protein (FAP) which is upregulated in most solid tumours compared
with healthy tissues. The pre|CISION™ platform harnesses this tumour
specific protease to activate pre|CISION™ peptide drug conjugates and
pre|CISION™ antibody/Affimer(®) drug conjugates in the tumour
microenvironment, reducing systemic exposure and toxicity, allowing dosing to
be optimised to deliver the best outcomes for patients.
The lead pre|CISION™ programme AVA6000, a peptide drug conjugate form of
doxorubicin, is in Phase 1 studies. It has shown an improvement in safety and
tolerability in clinical trials to date compared with standard doxorubicin and
preliminary signs of clinical activity in multiple patients.
To register for news alerts by email go
to www.avacta.com/investor-news-email-alerts
(http://www.avacta.com/investor-news-email-alerts)
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Christina Coughlin
2. Reason for the Notification
a) Position/status Chief Executive Officer
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Avacta Group Plc
b) LEI 2138009U3EG31OPMGH36
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument
Options over Ordinary Shares
Identification code GB00BYYW9G87
b) Nature of the transaction
Grant of Options over Ordinary Shares
c) Price(s) and volume(s)
LTIP
Exercise Price(s) Volume(s)
72.00 pence 3,600,000
d) Aggregated information: As above
· Aggregated volume
· Price
e) Date of the transaction 30 August 2024
f) Place of the transaction Outside a trading venue
3.
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a)
Name
Avacta Group Plc
b)
LEI
2138009U3EG31OPMGH36
4.
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Options over Ordinary Shares
Identification code
GB00BYYW9G87
b)
Nature of the transaction
Grant of Options over Ordinary Shares
c)
Price(s) and volume(s)
LTIP
Exercise Price(s) Volume(s)
72.00 pence 3,600,000
d)
Aggregated information:
· Aggregated volume
· Price
As above
e)
Date of the transaction
30 August 2024
f)
Place of the transaction
Outside a trading venue
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Tony Gardiner
2. Reason for the Notification
a) Position/status Chief Financial Officer
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Avacta Group Plc
b) LEI 2138009U3EG31OPMGH36
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument
Ordinary Shares
Identification code GB00BYYW9G87
b) Nature of the transaction
Exercise of Options over Ordinary Shares
c) Price(s) and volume(s)
LTIP
Exercise Price(s) Volume(s)
10.0 pence 500,000
d) Aggregated information: As above
· Aggregated volume
· Price
e) Date of the transaction 30 August 2024
f) Place of the transaction Outside a trading venue
3.
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a)
Name
Avacta Group Plc
b)
LEI
2138009U3EG31OPMGH36
4.
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary Shares
Identification code
GB00BYYW9G87
b)
Nature of the transaction
Exercise of Options over Ordinary Shares
c)
Price(s) and volume(s)
LTIP
Exercise Price(s) Volume(s)
10.0 pence 500,000
d)
Aggregated information:
· Aggregated volume
· Price
As above
e)
Date of the transaction
30 August 2024
f)
Place of the transaction
Outside a trading venue
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Tony Gardiner
2. Reason for the Notification
a) Position/status Chief Financial Officer
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Avacta Group Plc
b) LEI 2138009U3EG31OPMGH36
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument
Ordinary Shares
Identification code GB00BYYW9G87
b) Nature of the transaction
Sale of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
71.07 pence 500,000
d) Aggregated information: As above
· Aggregated volume
· Price
e) Date of the transaction 30 August 2024
f) Place of the transaction London Stock Exchange, AIM Market
3.
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a)
Name
Avacta Group Plc
b)
LEI
2138009U3EG31OPMGH36
4.
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary Shares
Identification code
GB00BYYW9G87
b)
Nature of the transaction
Sale of Ordinary Shares
c)
Price(s) and volume(s)
Price(s) Volume(s)
71.07 pence 500,000
d)
Aggregated information:
· Aggregated volume
· Price
As above
e)
Date of the transaction
30 August 2024
f)
Place of the transaction
London Stock Exchange, AIM Market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUUSSRSKUKRARRecent news on Avacta
See all newsREG - Avacta Group PLC - Board change
AnnouncementREG - Avacta Group PLC - Block Listing Six Monthly Return
AnnouncementREG - Avacta Group PLC - Avacta presents preclinical data at AACR
AnnouncementREG - Avacta Group PLC - Avacta presents data from lead candidate at AACR
AnnouncementREG - AIM - AIM Notice - 24/04/2025
Announcement